Episode 6 – The "One-Two Punch" of Abeta and Tau

Saving Minds

English - May 28, 2019 10:45 - 13 minutes - 12.9 MB - ★★★★★ - 30 ratings
Medicine Health & Fitness Business Investing alzheimers parkinsons pharma promis Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Episode 5 – Major Late-stage Alzheimer's Failures

Next Episode: Episode 7 – Dr. Johanne Kaplan on the Importance of Selectivity

Toxic tau and amyloid-beta are the two most validated drug targets for an Alzheimers disease therapy. Elliot and Shanti discuss tau, its role as a root cause of Alzheimer's disease and its involvement in 80 other diseases known as tauopathies.